Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 101,500 |
|
|||||
| News | - | ||||||
| Day High | 3.74 | Low High |
|||||
| Day Low | 3.59 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| PDS Biotechnology Corporation | PDSB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 1.11% | 3.65 | 09:32:49 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.71 | 3.59 | 3.74 | 3.61 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 484 | 101,500 | US$ 3.65 | US$ 370,653 | - | 2.59 - 10.27 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:32:48 | 7,493 | US$ 3.65 | USD |
PDS Biotechnology Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 113.54M | 31.11M | - | 0 | -42.94M | -1.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PDS Biotechnology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PDSB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.14 | 3.82 | 3.1212 | 3.41 | 441,525 | 0.51 | 16.24% |
| 1 Month | 3.69 | 3.82 | 2.59 | 3.12 | 727,555 | -0.04 | -1.08% |
| 3 Months | 5.26 | 6.68 | 2.59 | 4.52 | 934,242 | -1.61 | -30.61% |
| 6 Months | 4.20 | 6.85 | 2.59 | 4.82 | 759,439 | -0.55 | -13.10% |
| 1 Year | 6.06 | 10.27 | 2.59 | 5.38 | 726,008 | -2.41 | -39.77% |
| 3 Years | 5.79 | 17.85 | 2.59 | 7.24 | 683,591 | -2.14 | -36.96% |
| 5 Years | 5.57 | 17.85 | 0.6153 | 5.70 | 681,116 | -1.92 | -34.47% |
PDS Biotechnology Description
| PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. |
